The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy

Journal of Pediatrics

Volumn 145, Issue 2 SUPPL., 2004, Pages

  Pidcock, Frank S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

CEREBRAL PALSY; HUMAN; MUSCLE TONE; PATIENT SELECTION; PRIORITY JOURNAL; SHORT SURVEY; SPASTICITY;

EID: 4043163296     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.05.020     Document Type: Article

References (38)

1. L.A. Koman, J.F. Mooney, B.P. Smith, A. Goodman, and T. Mulvaney Management of spasticity in cerebral palsy with botulinum toxin-A: preliminary investigation J Pediatr Orthop 13 1993 489 495
2. Cerebral palsy - facts & figures. United Cerebral Palsy Association Internet fact sheet. Available at: http://www.ucp.org.
3. R.N. Boyd, and R.M. Hays Current evidence for the use of botulinum toxin A in the management of children with cerebral palsy: a systematic review Eur J Neurol 8 suppl 5 1993 1 20
4. T.S. Edgar Clinical utility of botulinum toxin in the treatment of cerebral palsy: comprehensive review J Child Neurol 16 1993 37 46
5. R.N. Boyd, F. Dobson, J. Parrott, S. Love, J. Oates, and A. Larson The effect of botulinum toxin A and a variable hip abduction orthosis on gross motor function - a randomized controlled trial Eur J Neurol 8 suppl 5 2001 109 119
6. ®) for the treatment of dynamic equinus spasticity associated with cerebral palsy: results of double blind, placebo controlled dose ranging study [abstract] Gait Posture 12 2000 64 65
7. S.C. Love, J.P. Valentine, E.M. Blair, and C.J. Price The effect of botulinum toxin A on the functional ability of the child with spastic hemiplegia: a randomized controlled trial Eur J Neurol 8 suppl 5 2001 50 58
8. H. Forssberg, and K.B. Tedroff Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation? Dev Med Child Neurol 39 1997 635 640
9. G.L. Sheean Botulinum treatment of spasticity: why is it so difficult to show a functional benefit? Curr Opin Neurol 14 2001 771 776
10. D.B. Lacy, W. Tepp, A.C. Cohen, B.R. DasGupta, and R.C. Stevens Crystal structure of botulinum neurotoxin A and implications for toxicity Nat Struc Biol 5 1998 898 902
11. E.J. Schantz, and E.A. Johnson Properties and use of botulinum toxin and other microbial neurotoxins in medicine Mircobiol Rev 56 1992 80 99
12. L.A. Koman, B.P. Smith, and A. Goodman Botulinum toxin A in the management of cerebral palsy 2002 Wake Forest University Press Winston-Salem, NC p. 1-3
13. K.R. Aoki Pharmacology and immunology of botulinum toxin serotypes J Neurol 248 suppl 1 2001 3 10
14. K.R. Aoki, and B. Guyer Botulinum toxin A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions Eur J Neurol 18 suppl 5 2001 21 29
15. A. dePaiva, F.A. Meunier, J. Molgo, K.R. Aoki, and J.O. Dolly Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals Proc Natl Acad Sci U S A 96 1999 3200 3205
16. N. Mahant, P.D. Clouston, and I.T. Lorentz The current use of botulinum toxin J Clin Neurosci 7 2000 389 394
17. L.J. Carr, A.P. Cosgrove, P. Gringras, and B.G. Neville Position paper on the use of botulinum toxin in cerebral palsy. UK Botulinum Toxin and Cerebral Palsy Working Party Arch Dis Child 79 1998 271 273
18. J.A. Kawiecki, M.E. Gormley, E. Ballard, and J. Windorski Transient loss of visual accommodation in a pediatric patient after botulinum toxin type B injections: a case report [abstract] Arch Phys Med Rehabil 83 2002 1674
19. M. Gormley, G. Herring, and D. Gaebler-Spira The use of botulinum toxin in children: a retrospective study of adverse reactions and treatment of idiopathic toe-walking Eur J Neurol 4 suppl 2 1997 27 30
20. F.S. Pidcock Familyreported effects of botulinum toxin treatments for spasticity [poster] Mov Disord 15 suppl 2 2000 49
21. Bernard C. La Science Experimentale 1875;237.
22. A.B. Scott, A. Rosenbaum, and C.C. Collins Pharmacologic weakening of extraocular muscles Invest Ophthalmol 12 1973 924 927
23. La. Koman, J.F. Mooney, T. Mulvaney, S. Roberts, and B.P. Smith Further evaluation of botulinum A toxin (BOTOX) in the management of cerebral palsy Dev Med Child Neurol 35 1993 29 30
24. A.P. Cosgrove, I.S. Corry, and H.K. Graham Botulinum toxin in the management of the lower limb in cerebral palsy Dev Med Child Neurol 36 1994 386 396
25. Is. Corry, A.P. Cosgrove, E.G. Walsh, D. McClean, and H.K. Graham Botulinum toxin A in the hemiplegic upper limb: a double blinded trial Dev Med Child Neurol 39 1997 185 193
26. I.S. Corry, A.P. Cosgrove, C.M. Duffy, T.C. Taylor, and H.K. Graham Botulinum toxin A in hamstring spasticity Gait Posture 10 1999 206 210
27. D.H. Sutherland, K.R. Kaufman, M.P. Wyatt, H.G. Chambers, and S.J. Mubarak Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy Gait Posture 10 1999 1 9
28. V.A. Fehlings, M. Rang, J. Glazier, and C. Stelle An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy J Pediatr 137 2000 331 337
29. R.N. Boyd, V. Pliatsios, R. Starr, R. Wolfe, and H.K. Graham Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy Dev Med Child Neurol 42 2000 32 41
30. G. Molenaers, M. Eyssen, K. Desloovere, I. Jonkers, and P. DeCock A multilevel approach to botulinum toxin type A treatment of the (ilio)psoas in spasticity in cerebral palsy Eur J Neurol 6 suppl 4 1999 51 57
31. N.W. Eames, R. Baker, N. Hill, H.K. Graham, T. Taylor, and A. Cosgrove The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response Dev Med Child Neurol 41 1999 226 232
32. A. Brashear, M.F. Gordon, E. Elovic, V.D. Kassicieh, C. Marciniak, and M. Do Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke N Engl J Med 347 2002 395 400
33. M. Delgado Investigation of botulinum toxin type-A for the treatment of juvenile cerebral palsy Toxins '99 1 1999 6 7
34. F. Gilio, A. Curra, C. Lorenzano, N. Modugno, M. Manfredi, and A. Berardelli Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia Ann Neurol 48 2000 20 26
35. E.S. Park, C.I. Park, D.Y. Kim, and Y.R. Kim The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection Arch Phys Med Rehabil 83 2002 1592 1596
36. F. Pauri, L. Boffa, E. Cassetta, P. Pasqualetti, and P.M. Rossini Botulinum toxin type-A treatment in spastic paraparesis: a neurophysiological study J Neurol Sci 181 2000 89 97
37. M.L. Byrnes, G.W. Thickbroom, S.A. Wilson, P. Sacco, J.M. Shipman, and R. Stell The corticomotor representation of upper limb muscles in writer's cramp and changes following botulinum toxin injection Brain 121 1998 977 988
38. Heinen F, Mall V, Berweck S, Fietzek U, Kirschner J. Critical issues in the use of botulinum toxin A [handout]. European Academy of Childhood Disability, 12th Annual Meeting, Tubingen, Germany, 2000.